In an ancillary study of prostate cancer survivors who recently participated in an exercise trial, we had an opportunity to assess whether the gut microbiome is associated with cognitive measures in men with prostate cancer treated with ADT, and whether the APOE genotype, exercise history, and salivary testosterone levels modulate this relationship. This evidence concerns the gene APOE and prostate carcinoma.